Author

Yu Fan

National Institutes of HealthORCID 0000-0002-7473-6104Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Yu Fan4 papers · Tsinghua University

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Assay:electronic health records· 1 Organism:human· 1 Research Focus:metabolism & bioenergetics· 1 Organism:mouse· 1

Frequent Co-Authors

Ananda Chowdhury· 1 shared Ariana VitaleiD· 1 shared Christopher W. DelliD· 1 shared Daniel W. McVicariD· 1 shared Daoud M. MeerzamaniD· 1 shared Daoud Meerzaman· 1 shared David PeeneyiD· 1 shared Duncan E. DonohueiD· 1 shared

Activity by Year

2023-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ananda Chowdhury

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyCancer Research CommunicationsPeer-reviewedFeb 18, 2026

A simple liquid 3D cell culture paradigm models oxidative mitochondrial metabolism of epithelial breast cancer cells with relevance for lung metastases.

Kuppusamy Balamurugan, Melissa R. Mikolaj, Jonathan M. Weiss…·Esta Sterneck

This paper compares two 3D culture models for breast cancer cells, finding that the EmC model better mimics lung metastasis by altering metabolism and gene expression.

1 citation

humanproteomics

𝕏 PostBluesky

Cancer BiologybioRxivDec 29, 2023

Timp2 loss-of-function mutation and TIMP2 treatment in murine model of NSCLC: modulation of immunosuppression and oncogenic signaling

David Peeney, Sarvesh Kumar, Tej Pratap Singh…·William G. Stetler-Stevenson

TIMP2 treatment compensates for TIMP2 mutation to reveal immunomodulatory and oncogene regulation that inhibits tumor growth and metastatic niche formation.

DOI 10.1016/j.tranon.2025.102309

mousebulk RNA-seq

𝕏 PostBluesky